Literature DB >> 32556134

EPCR knockout: inflaming the discussion.

Dougald Monroe1, Maureane Hoffman2,3.   

Abstract

Entities:  

Year:  2020        PMID： 32556134      PMCID： PMC7316206          DOI： 10.1182/blood.2020006001

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  IL-1β, in contrast to TNFα, is pivotal in blood-induced cartilage damage and is a potential target for therapy.

Authors:  Lize F D van Vulpen; Roger E G Schutgens; Katja Coeleveld; Els C Alsema; Goris Roosendaal; Simon C Mastbergen; Floris P J G Lafeber
Journal:  Blood       Date:  2015-08-14       Impact factor: 22.113

2.  The endothelial protein C receptor enhances hemostasis of FVIIa administration in hemophilic mice in vivo.

Authors:  Giulia Pavani; Lacramioara Ivanciu; Armida Faella; Oscar A Marcos-Contreras; Paris Margaritis
Journal:  Blood       Date:  2014-06-23       Impact factor: 22.113

3.  IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia.

Authors:  N Narkbunnam; J Sun; G Hu; F-C Lin; T A Bateman; M Mihara; P E Monahan
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

Review 4.  Wound healing in haemophilia--breaking the vicious cycle.

Authors:  M Hoffman; D M Monroe
Journal:  Haemophilia       Date:  2010-05       Impact factor: 4.287

5.  Factor VIIa interaction with EPCR modulates the hemostatic effect of rFVIIa in hemophilia therapy: Mode of its action.

Authors:  Shiva Keshava; Jagan Sundaram; Anuradha Rajulapati; Charles Esmon; Usha Pendurthi; L Vijaya Mohan Rao
Journal:  Blood Adv       Date:  2017-06-27

6.  EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.

Authors:  Jhansi Magisetty; Usha R Pendurthi; Charles T Esmon; L Vijaya Mohan Rao
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

Review 7.  The protein C pathway.

Authors:  Charles T Esmon
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

8.  Factor VIIa binding to endothelial cell protein C receptor protects vascular barrier integrity in vivo.

Authors:  J Sundaram; S Keshava; R Gopalakrishnan; C T Esmon; U R Pendurthi; L V M Rao
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

9.  A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy.

Authors:  Feixu Zhang; Mengyang Xu; Qin Yang; Baolai Hua; Binglan Xia; Zhenyang Lin; Xiao Xiao; Paul E Monahan; Junjiang Sun
Journal:  J Clin Med       Date:  2019-12-27       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.